Wyeth Shareholders Seek Class Cert. In Pristiq Suit
A Massachusetts pension fund asked a New York federal court Friday to certify a class of investors who claim that Pfizer Inc. unit Wyeth Pharmaceuticals Inc. obscured possibly serious side effects...To view the full article, register now.
Already a subscriber? Click here to view full article